Research Methodology – Ankylosing Spondylitis Market
At Straits Research, we adopt a rigorous 360° research approach that integrates both primary and secondary research methodologies. This ensures accuracy, reliability, and actionable insights for stakeholders. Our methodology for the Ankylosing Spondylitis Market comprises the following key stages:
Market Indicator & Macro-Factor Analysis
Our baseline thesis for the Ankylosing Spondylitis Market is developed by integrating key market indicators and macroeconomic variables. These include:
Factors considered while calculating market size and share
- The number of diagnosed cases of Ankylosing Spondylitis globally and regionally.
- The prevalence and incidence rate of Ankylosing Spondylitis.
- Treatment approaches and therapies available for Ankylosing Spondylitis and the cost related to these treatments.
- Demand for Ankylosing Spondylitis treatments in different regions.
- The number of hospitals and clinics providing treatment for Ankylosing Spondylitis.
- Public and private healthcare expenditure on Ankylosing Spondylitis treatments.
- Market presence and dominance of leading pharmaceutical companies and their product portfolio.
- Pricing strategy employed by the pharmaceutical companies for Ankylosing Spondylitis drugs.
- Impact of healthcare policies and insurance coverage for treatment.
Key Market Indicators
- The compound annual growth rate (CAGR) of the Ankylosing Spondylitis market.
- The total market revenue and sales volume of Ankylosing Spondylitis treatments.
- Year-on-Year (Y-o-Y) growth rate of the Ankylosing Spondylitis market.
- Pipeline products and recent developments by key market players.
- The number of medical professionals specializing in treating Ankylosing Spondylitis.
- Changes in healthcare expenditure towards Ankylosing Spondylitis.
- Changes in reimbursement and insurance scenarios related to Ankylosing Spondylitis.
Growth Trends
- The adoption rate of biologics and non-steroidal anti-inflammatory drugs (NSAIDs) for Ankylosing Spondylitis treatment.
- Growth in healthcare infrastructure and increased healthcare spending towards rheumatic diseases.
- Increasing awareness and understanding of Ankylosing Spondylitis among the general population.
- Research and development activities in Ankylosing Spondylitis and introduction of new treatment options.
- The impact of digital health technology on Ankylosing Spondylitis management.
- Changes in lifestyle factors leading to an increase or decrease in Ankylosing Spondylitis cases.
Secondary Research
Our secondary research forms the foundation of market understanding and scope definition. We collect and analyze information from multiple reliable sources to map the overall ecosystem of the Ankylosing Spondylitis Market. Key inputs include:
- Annual reports, investor presentations, SEC filings
- Company press releases and product launch announcements
- Public executive interviews and earnings calls
- Strategy briefings and M&A updates
- Country-level industry associations and trade bodies
- Government dossiers, policy frameworks, and official releases
- Whitepapers, working papers, and public R&D initiatives
- Relevant Associations for the Ankylosing Spondylitis Market
- Broker reports and financial analyst coverage
- Paid databases (Hoovers, Factiva, Refinitiv, Reuters, Statista, etc.)
- Import/export trade data and tariff databases
- Sector-specific journals, magazines, and news portals
- Global macroeconomic indicators and their cascading effect on the industry
- Demand–supply outlook and value chain analysis
- Consumer behaviour, adoption rates, and commercialization trends
Primary Research
To validate and enrich our secondary findings, we conduct extensive primary research with industry stakeholders across the value chain. This ensures we capture both qualitative insights and quantitative validation. Our primary research includes:
- Key Opinion Leader (KOL) Engagements
- Structured interviews with executives, product managers, and domain experts
- Paid and barter-based interviews across manufacturers, distributors, and end-users
- Discussions with stakeholders to validate demand-supply gaps
- Group discussions on emerging technologies, regulatory shifts, and adoption barriers
- Cross-verification of market sizing and forecasts with industry insiders
- Capturing business perspectives on growth opportunities and restraints
Data Triangulation & Forecasting
The final step of our research involves data triangulation ensuring accuracy through cross-verification of:
- Demand-side analysis (consumption patterns, adoption trends, customer spending)
- Supply-side analysis (production, capacity, distribution, and market availability)
- Macroeconomic & microeconomic impact factors
- Time-series analysis
- Regression and correlation studies
- Baseline modeling
- Expert validation at each stage
Outcome
The outcome is a comprehensive and validated market model that captures:
- Market sizing (historical, current, forecast)
- Growth drivers and restraints
- Opportunity mapping and investment hotspots
- Competitive positioning and strategic insights
Available for purchase with detailed segment data, forecasts, and regional insights.
Get This ReportOur Clients:
